Skip to content
Home/Companies/Biotech/Ferrokin Biosciences Inc.

Ferrokin Biosciences Inc.

Biotech·United States·Exited 2012·Held 3yr
Entry
2009
Hold
3yr
Exit
2012

Who owns Ferrokin Biosciences Inc.?

Ferrokin Biosciences Inc. is an American Biotech company, now owned by Shire, which acquired it in 2012 from HealthCap.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
HealthCap
Investor
HealthCap
HealthCap VI · 2008 · VC

Key facts

HQUnited States
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
Shire
Exit Year
2012

More from HealthCap VI

Other portfolio companies in the same fund.

GenSight Biologics S.A.
Exited 2016
BiotechFrance· 2015
Glionova AB
Active
BiotechSweden· 2014
Xeris Biopharma Holdings, Inc (Strongbridge)
Exited 2021
PharmaUS· 2014
to Xeris Pharmaceuticals
Nordic Nanovector AS
Exited 2015
BiotechNO· 2013
Oncopeptides AB
Exited 2017
BiotechSE· 2013
Wilson Therapeutics AB
Exited 2018
PharmaSweden· 2012
to Alexion Pharmaceuticals

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Ferrokin Biosciences Inc.?

Ferrokin Biosciences Inc. is now owned by Shire, which acquired it in 2012 from HealthCap.

When did Shire acquire Ferrokin Biosciences Inc.?

Shire acquired Ferrokin Biosciences Inc. in 2012, buying from HealthCap.

Who did Ferrokin Biosciences Inc. sell to?

HealthCap sold Ferrokin Biosciences Inc. to Shire in 2012 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue